Short answer
SANUWAVE Health, Inc. (SNWV) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $11M (up 22.3% year over year) with net income of $10M.
Q3 2025 key financials · XBRL
- Revenue
- $11M
- +22.3% YoY · +12.7% QoQ
- Net income
- $10M
- +150.0% YoY · +878.7% QoQ
- Operating margin
- 12.8%
- Gross margin
- 77.9%
- EPS (diluted)
- $0.92
- +115.5% YoY · +666.7% QoQ
Source: XBRL data from the SANUWAVE Health, Inc. (SNWV) Q3 2025 10-Q on SEC EDGAR. USD.
SANUWAVE Health, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $11.5M, up 22% YoY from $9.4M, driven by UltraMIST disposables and systems
- Gross margin 78% vs 76% YoY; operating income $1.5M vs $2.0M
- UltraMIST represented 99% of revenue; disposables volume up 23%, systems volume up 25%
- Operating cash flow $0.6M vs $1.7M; investing cash flow $3.2M, including $5.0M patent proceeds
- Debt refinancing extended maturities and added revolving-credit liquidity; management expects resources sufficient for 12 months
Risk Factors
- New tax-attribute limitation triggered by IRC Section 382 analysis during quarter ended June 30, 2025
- $44.2 million of NOL tax attributes expected to expire before availability due to ownership shifts
- Federal and state NOL carryforwards begin expiring after 2033
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SANUWAVE Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.